REGISTERED CHARITY NUMBER: 800952
REPORT OF THE TRUSTEES AND
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
FOR
THE KIDNEY FUND
GBJ LLP
Sterling House
27 Hatchlands Road
Redhill
Surrey
RH16RW

THE KIDNEY FUND
CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
Page
R8POrt of the Trustees
Indopendent Examlnerfs Report
statemant of Flnanclal Activities
Balance Sheet
Notes to the Flnancial Statsmonts
6 to 12
Dotailgd Statement of Flnancial Activities
13 to 14

THE KIDNEY FUND
REPORT OF THE TRUSTEES
FOR THE YEAR ENDED 31 MARCH 2024
The trustees present their report with the financial statements of the charity for the year ended 31 March 2024.
The trustees have adopted the provtsions of Accounting and Reporting by Charities.. Statement of Recommended
Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Stsndard
applicable in the UK and Republic of Ireland IFRS 102) {effective 1 January 2019).
OBJECTIVES AND ACTIVITIES
Obloctlves and aims
The Charity ("Ihe Fund") is constituted by a Trust Deed and was established to build a Resear¢h InstitLrte and to
promot8 research into renal failure and diabetes. A storey Fxjrposè built laboratory block was completed In
1997 and in March 1998, Lord Rogers formally opened the South West Thames Institute for Renal Research
c'the swfiRR") which is incorporated as an independent company limited by guarantee. Money Continues to be
needed to fund the ongoing research of the swfiRR and to publish useful results for the benefit of renal patients.
Grants are given regularly by the Fund to SV￿lRR. The promotion of research into renal failure and diabetes
ontinues to be the key objective of the Fund.
Slgnificant actlvltias
The Fund has continued its main activty of supporting the South West Thames Institute of Renal Research
(swriRRI. During the year 2023-2024, The Kidney fund provided a Core grant of £ 132,794 10 8UPPOrt the work
of swfiRR, £40,000 to the Kidney Research UK and £86,041to the Kings College, to enable one of its sludents
to undertake research. Thls research project will be undertaken over a three -year period and Ihe Kidney Fund 's
contribution for this Project will be lotalled over £275,000.
The income from various fundraising activities contributed £32,156 Compared to £52,722 raised in the year
202-2023. The Trustees ar8 most grateful to those who have worked hard in difficult circumstances to organise
fundraising events and w8 value the time, energy, and efforts they have put in to raise funds for the Charfly
During the year, the Fund received three legacies totalling £ 284,786. Our thanks are due to these Individuals who
have remembered the Charity in their wills and to individual donors who had ¢ontrlbuted to our funds during the
year.
Publlc benefjt
The Kidney Fund provides public bènefit as a charity by..
o Supporting research into the nature, causes, diagnosis and treatment of renal failure and dlabetes.
o Raising awareness and advancing pub15c education In all areas relating to kidney disease.
The truslees have Considered the Charity Commission's general guidance on public benefit and have taken it into
account when reviewing The Charity's aims and objectives and in planning its future activities. The Trustees are
satisfied that the aims of The Charty are carried out wholly in pursuit of its charitsble aims for the public benefit.
FINANCIAL REVIEW
Flnancial posltion
The accounts of the year show a surplus on unrestricted funds of £95,687 and total Un￿StrICted fund carried
forward at 31 st March 2024 of£600.814. Restricted Funds at the yearend lolalled £42,261
The Trustee5 consider that the assets of the funds as disclosed in the flnancial statements are adequate to
enable it to wntinue to fulfil its obligations. The Trustees are committed to Continue to explore ways to raise
additional funds to fulfil its obligations to support s￿IRR in its internationally recognised research work.
Page 1

YHE KIDNEY FIIND
REIXIRT OF THE TRUSTEES
FOR THE YEAR ENDED 31 MARCH 2024
STRUCTURE. GOVERNANCEAND MANAGEMENT
The diarity is contrclad by Its govemiNJ dwmenL 8 deed of InJs( constStth An unInCorp￿ated
charity. The Board of Tru8tse¥ operated during the year with srx Membe￿ Meelings hav& boen held on Zoom
to direct, oversee and assess the administrati¢)n of Iha Chartty and consider opportunllies for fuhd ralslng. ￿1
trustees yve of th8ir tlme freely and no trustee reMun￿atIOn was paid in the year. Day to day admlnlstraticn of
the Kidnoy Fund Is being cathed by a part time Admirfstrator.
REFERENCE AND ADMINISTRATIVE DEfAILS
Reg18terod Charfty numbor
800952
Prlnclpal addres8
The Renal Unit
st HelierHo$pital
Wrylh8 Lano
Carshaiton
Surr8y
SM51
Truste04
Dr M R BeTrJlng
Miss A Ab8na-Amoako
Dr D Mak8njuola
C Howard
NF
G Hooper
R Ford {Resigned 18104r2023)
Mrs L Palomino (Resigned 2210212024>
J J Ho8sain IRe8igned 24105r2023)
Independent Examlner
Jonathan Hilller FCCAACA
GBJ LLP
Slerfing House
27 Hatchlands Road
Redhlll
Sufrgy
RH16RW
stoekbYoker8
JMFinn&Co
4 Coleman Street
London
EC2R 5fA
Approved byorderoftheboardoftJu$ieesJ￿..............-...-........,.. ...,..... ....and sfjgned on Its behalfty.
Hoop
r- Trustea
Page 2

INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF
THE KIDNEY FUND
Independont examlner's report to the trustees of Tho Kidney Fund
I report to the charity trustees on my examination of the accounts of The Kidney Fund (the Trust) for the year
ended 31 March 2024.
Responslblllties and basls of report
As the Charity trustees of the Tnjst you are responsible for the preparalion of the a¢¢ounts in accordance with the
requirements of the Charities Act 2011 {'the Acf ).
I report in respect of my examination of the Trusvs accounts carried out under Section 145 of the Act and in
carrying out my examination I have followed all applicable Directions given by the Charity Commission under
Section 145(5)(b) of the Act.
Independent examiner's statement
Since your charity's gross in¢ome ex￿eded £250,000 your examiner must be a member of a listed body. I can
confim that l am qualified to undertake the examination because l am a member of the Institute of Chartered
Accountants in England and Wales, which is one of the listed bodie8.
I have completed my examination. I confimi that no material matters have come to my attention In ¢onnectl¢n
th the examination giving me Cause to believ8 that in any material respect:
accounting recAirds were not kept in respect of the Trust as required by Seciion 130 of the AGt' or
the accounts do not accord with those records,. or
the accounts do not comply with the applicable requirements conoming the form and content of accounts
sel out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the
accounts glve a true and fair view which is not a matter conSide￿d as part of an independent examination.
I have no concems and have come across no other matters in connection wlth the examination to which attention
should be drawn in this report in order to enable a proper understanding of the aGGounts to be reached.
Jonathan Hillier FCCA ACA
GBJ LLP
Sterling House
27 Hatchlands Road
Redhill
Surrey
RH16RW
2 October 2024
Page 3

THE KIDNEY FUND
STATEMENT OF FINANCIAL ACTIVITIES
FOR THE YEAR ENDED 31 MARCH 2024
2024
Total
funds
2023
Tolal
fund8
Unreslricted
fvnds
Restricted
fund
Notes
INCOME AND ENDOWMENTS FROM
Donations and legacigs
352,821
352,821
416,328
Charitable activities
Fundraising
(10,375
{10,375)
{16,486)
other trading a¢tivllle$
Investment income
32,159
11,397
32,159
11,397
52,722
7,085
Total
386,002
386,002
459,649
EXPENDITURE ON
Raising fund8
Raising donations and legacies
Investment management costs
25,083
1,375
25,083
1,375
18,625
1,283
26,458
26,458
19,908
¢harltable a￿1VItIeS
SWITTR
172,794
86,041
921
Z Baalawy Kings College
173,715
86.041
108.000
Totsl
285,293
921
286,214
127,908
Net gainsl{lossesl on Investrnents
(5,022
(5,022
{12,444)
NET INCOMEI(EXPENDITURE)
95,687
1921)
94,766
319.297
RECONCILIATION OF FUNDS
Total funds brought forward
505,127
43,182
648,309
229,012
TOTAL FUNDS CARRIED FORWARD
600,814
42.261
643,075
548,309
The notes fomi part of these financial statements
Page 4

THE KIDNEY FUND
BALANCE SHEEr
31 MARCH 2024
2024
Total
funds
Unrestric
funds
2023
Total
funds
Restricied
fund
FIXED ASSETS
Soclal Investments
Notes
153,540
153,540
160,234
CURRENT ASSETS
Debtors
Cash at bank ond In hand
23,471
428,063
23.471
470.324
279
391,706
42,261
451.534
42,261
493,795
391,98S
CREE)ITORS
Amounts falllng due wlthin one year
10
(1,110)
NET CURRENf ASSETS
451,534
42,261
493,795
390.875
TOTAL ASSEfs LESS CURRENT
LIABILITIES
605,074
42,261
647,335
551.109
ACCRUALS AND DEFERRED INCOME
12
(4,260)
(4,2801
(2,800)
NET ASSETS
600,814
42,261
643,075
548.309
FUNDS
Unreslricted funds
R8strict8d funds
13
600,814
42.261
505,127
43,182
TOTAL FUNDS
643,075
548.309
The fln8ncial statements were approved by the Board of TNste88 and authorlsed for issu8 on
I41.￿L.T￿ljA.*....￿ &A￿..... and were Signed on Sts behalf by..
oper- Truste8
Th6 notas fonn part of th8Be financial statements
Page 5

THE KIDNEY FUND
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
ACCOUNTING POLICIES
Basis of proparing the financial statements
The financial statements of the charity, which is a public benefit entity under FRS 102, have been
prepared in accordance with the Charities SORP IFRS 102) 'Accounling and Reporting by Charit18S=
Statement of Recommended Practice applicable to ¢hariÉies preparing their accounts in accordance with
the Financial Reporting Standard applicable in the UK and Republi¢ of Ireland {FRS 102) (effective 1
January 2019),. Financial Reporting Stsndard 102 'The Financial Reporting Standard applicable in the UK
and Republic of Ireland, and the Charities Act 2011. The financial statements have been prepared under
the histori￿1 cost convention, as modified by the revaluation of certain ass&ts.
Incom8
All income Is recognised In the Statement of Financial Adivities once the charity has entitlement to the
funds, it 1$ probable that the incvme will be re￿iVed and the amount can be m8asured reliably.
Expendlture
Liabilities are recognised as expenditure as soon as there is a legal or ¢onstnJctive obligation committing
the charity to that expenditure, it is probable that a transf8r of economic benefits will be required in
settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an
accruals basis and has been classified under headSngs that aggregate all cost related to the category.
Where costs cannot be directly attributed to particular headings they have been allocated to activities on a
basls consistent with the use of resources.
Grants offered subject to conditions which have not been met at th8 year end date are noted as
¢ommitrnent but not accrued as expenditure.
Social Invesbnonts
Social investments are form of finandal instrument and are initially reeognised at their transactions cost
and subsequently measured at fair vale at the Balantt Sheet date, unless the value cannot be measured
reliably in which case il is measured at cost less impairment. Investmènt gain8 and losses. whether
realised or unreallsed, a￿ combined and presented as 'Gainsl(Losses) on Investments. In the Statement
of financial activities.
Taxation
The charity is exempt from tax on hts charitable actlvilies.
Fund accounting
Unrestricted fvnds can be used In accordance with the chadtable oblectlves at the dlscretion of the
trustees.
Restricted funds can only be used for particular restricted purposes within the objects ot the charity.
Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.
Further explanation of the nature and purpose of each fund is induded in the notes to the financial
statements.
Page 6
Continued...

THE KIDNEY FUND
NOTES TO THE FINANCIAL STATEMENTS- continued
FOR THE YEAR ENDED 31 MARCH 2024
OTHER TRADING ACTIVITIES
2024
2023
Fundraising events
32,159
52.722
INVESTMENT INCOME
2024
2023
Other fixed asset invest- Fll
11,397
7,085
RAISING DONATIONS AND LEGACIES
2024
2023
Support costs
25,083
18,625
INVESTMENT MANAGEMENT COSTS
2024
2023
Portfollo management
1,375
1,283
TRUSTEES, REMUNERATION AND BENEFITS
There were no trustees, remuneration or other benefits for the year ended 31 March 2024 nor for the year
ended 31 March 2023.
Trustees. exponses
There were no trustees, expenses paid for th8 year ended 31 March 2024 nor for the year ended
31 March 2023.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestrict8d
funds
Restricted
fund
Total
funds
INCOME AND ENDOWMENTS FROM
Donation8 and legacies
394,328
22,000
416,328
Charitable actlvltlas
Fundraising
(16,486)
(16,486)
Other Irading activities
Investment income
52,722
7,085
52,722
7,085
Totsl
437,649
22.000
459,649
EXPENDITURE ON
Raising funds
Page 7
contfftued...

THE KIDNEY FUND
NOTES TO THE FINANCIAL STATEMENTS- continued
FOR THE YEAR ENDED 31 MARCH 2024
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted
Restricted
funds
fund
Total
funds
Raising donations and legacies
Investment management costs
18,625
1,283
18,625
1,283
19,908
19,908
Charltable activltles
SWITTR
108.000
108,000
Total
127,908
127,908
Net gain81(losses) on investments
<12,444)
(12,444)
NET INCOME
297,297
22,000
319,297
RECONCILIATION OF FUNDS
Total funds brought forward
207,830
21,182
229,012
TOTAL FUNDS CARRIED FORWARD
505,127
43,182
548,309
SOCIAL INVESTMENTS
Other
Inveslments
MARKET VALUE
At 1 April 2023
Additions
Disposals
Revaluations
160,234
9,989
{11,661)
<5,022)
At 31 March 2024
153,540
NET BOOK VALUE
At 31 March 2024
153,540
At 31 March 2023
160,234
Page 8
continued...

THE KIDNEY FUND
NOTES TO THE FINANCIAL STATEMENTS - contlnued
FOR THE YEAR ENDED 31 MARCH 2024
SOCIAL INVESTMENTS- continued
Cost or valuation at 31 Ma￿h 2024 is represented by:
Other
investment
Valuation in 2022
Valuation in 2023
Valuation in 2024
Cost
1,529
(12N44}
1,374
163.08
153,540
DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024
2023
other debtors
Prepayments
23,152
319
279
23,471
279
10. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024
2023
Bank loans and overdrafts (see note 11)
Other creditors
70
1,040
1,110
11. LOANS
An analysis of the maturity of loans is given below..
2024
2023
Amounts falllng due within one year on demand:
Bank overdrafts
70
Page 9
continued..

THE KIDNEY FUND
NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024
12. ACCRUALS AND DEFERRED INCOME
2024
2023
Accruals and def6rred income
4,260
2,800
13.
MOVEMENT IN FUNDS
Net
movement
in funds
At
31.3.24
At 1.4.23
Unrèstrlcted funds
General fund
505,127
95,687
600,814
Restricted funds
Reslricled Fund
43,182
(921)
42,261
TOTAL FUNDS
548,309
94.766
643,075
Net movement In funds, Included in the abov8 are as follows..
Incoming
resources
Resources
expended
Galns and
Iossgs
Movement
in funds
Unrestrlcted funds
General fvnd
386,002
1285,293
(5,022)
95,687
Restrlctsd funds
Restrict8d Fund
{921
(921
TOTAL FUNDS
386,002
1286,214)
(5,022)
94,766
Comparatives for movement In fund8
Net
movement
In funds
At
31.3.23
At 1.4.22
Unrestrlcted funds
General fund
207,830
297,297
505,127
Rostrlcted funds
Reslricted Fund .
21,182
22,000
43,182
TOTAL FUNDS
229.012
319,297
548,309
Page 10
¢ontinued...

THE KIDNEY FUND
NOTES TO THE FINANCIAL STATEMENTS- continuod
FOR THE YEAR ENDED 31 MARCH 2024
13.
MOVEMENT IN FUNDS- conunued
Comparative net movement in funds, Included in the above are as follows:
Incoming
resources
Resources
expended
Gains and
losses
Movement
in fvnds
Unrestricted funds
General fund
437,649
<127,908)
(12,444)
297,297
Restrlctsd funds
Restricted Fund
22,000
22.000
TOTAL FUNDS
459,649
(127,9081
(12.444)
319,297
A current year 12 months and prlor year 12 months combined posltlon Is as follows:
Net
movement
in funds
At
31.3.24
At 1.4.22
Unr•stricted funds
General fund
207.830
392,984
800,814
Restrfcted funds
R6Stricted Fund
21,182
21,079
42,281
TOTAL FUNDS
229,012
414,063
843,075
A current year 12 months and prior year 12 months comblned net movement in funds, induded in the
above are as follow$:
In￿mIng
sources
Resources
expended
Gains and
losses
Movement
in fvnds
Unrestricted fund8
General fund
823,651
(413,201)
(17,466)
392.984
Rastrictsd funds
Restricted Fund
22.000
{921)
21.079
TOTAL FUNDS
845.651
(414,1221
{17,466)
414,063
Page11
continued...

THE KIDNEY FUND
NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024
14.
RELATED PARTY DISCLOSURES
There were no related party transactions for the year ended 31 March 2024.
Page 12

THE KIDNEY FUND
DETAILED STATEMENT OF FINANCIAL ACTIVITIES
FOR THE YEAR ENDED 31 MARCH 2024
2024
2023
INCOME AND ENDOWMENTS
Donations and legacies
Donations
Legacies
68,035
284,786
53,648
362,680
352,821
416,328
Other trading activltle8
Fundraising events
32,159
52,722
Investmgnt income
other fixed asset invest - Fll
11,397
7,085
Charitabl8 actlvities
Fundraising Exps
110,3751
(16,4861
Total incomlng resources
386,002
459.649
EXPENDITURE
Investment management costs
Portfolio management
1,375
1,283
Charltsblo activltles
Grants to institutions
259,766
108,000
Support ¢osts
Management
Administrative @xpenses
21,994
15.658
Flnance
Bank charges
189
167
Governance costs
Accountancy and legal fees
2,900
2.800
Total resources expended
286.214
127,908
Net Incom8 before galns and losses
99.788
331,741
Realised recognlsed gains and losses
Carried forward
96,888
328,941
This page does not form part of the statutory financial statements
Page13

THE ￿DNEy FUND
DETAILED STATEMENT OF FINANCIAL ACTIVITIES
FOR THE YEAR ENDED 31 P4lARCH 2024
2024
2023
Realised recognlsed gains and losses
Brought forward
Realised gains/{losses) on fixed asset
investments
96,888
328,941
{5.022
(12,444>
Net Incom8
94.766
319,297
This page does not fomi part of the ststutory financial statemenis
Page 14